Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy

Affiliations

¹ IBD Unit, Gastroenterology Department, Hospital de Galdakao and, Biocruces Health Research Institute, Galdakao, Spain.
² IBD Unit, Gastroenterology Department, Hospital Universitario Donostia, Donostia-San Sebastián, Spain.
³ IBD Unit, Gastroenterology Department, Hospital de Galdakao and, Biocruces Bizkaia Health Research Institute, Galdakao, Spain.

Comment

Iago Rodríguez-Lago et al. Gastroenterology. 2021 Apr.

. 2021 Apr;160(5):1878-1880.

doi: 10.1053/j.gastro.2020.12.073. Epub 2021 Jan 5.

¹ IBD Unit, Gastroenterology Department, Hospital de Galdakao and, Biocruces Health Research Institute, Galdakao, Spain.
² IBD Unit, Gastroenterology Department, Hospital Universitario Donostia, Donostia-San Sebastián, Spain.
³ IBD Unit, Gastroenterology Department, Hospital de Galdakao and, Biocruces Bizkaia Health Research Institute, Galdakao, Spain.

No abstract available

Comment on

Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain).
Rodríguez-Lago I, Ramírez de la Piscina P, Elorza A, Merino O, Ortiz de Zárate J, Cabriada JL. Rodríguez-Lago I, et al. Gastroenterology. 2020 Aug;159(2):781-783. doi: 10.1053/j.gastro.2020.04.043. Epub 2020 Apr 21. Gastroenterology. 2020. PMID: 32330477 Free PMC article. No abstract available.
Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?
Macaluso FS, Orlando A. Macaluso FS, et al. Gastroenterology. 2021 Apr;160(5):1877-1878. doi: 10.1053/j.gastro.2020.05.026. Epub 2020 May 12. Gastroenterology. 2021. PMID: 32407807 Free PMC article. No abstract available.